Replies to post #169364 on Biotech Values

[oc631]

GILD's SVR12 results from the LONESTAR trial 8 weeks or 12 weeks

Do you think 8-weeks of Sofo/Ledi would show superior SVR rates to 12-weeks of Sofo/Ledi in GT1A patients within a large study (n=600)?